Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06266143
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-20
First Post:
2024-01-24
Brief Title:
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
Sponsor:
Wuhan YZY Biopharma Co Ltd
Organization:
Wuhan YZY Biopharma Co Ltd
Organization Data
Organization:
Wuhan YZY Biopharma Co Ltd
Class:
INDUSTRY
Study ID:
Y101D03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wuhan YZY Biopharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None